Javascript must be enabled to continue!
Bone marrow‐derived cells in palatal wound healing
View through CrossRef
Oral Diseases (2010) 16, 788–794Objective: Myofibroblasts are responsible for contraction and scarring after cleft palate repair. This leads to growth disturbances in the upper jaw. We hypothesized that cells from the bone marrow are recruited to palatal wounds and differentiate into myofibroblasts.Methods: We transplanted bone marrow from green fluorescent protein (GFP)‐transgenic rats into lethally irradiated wild‐type rats. After recovery, experimental wounds were made in the palatal mucoperiosteum, and harvested 2 weeks later. GFP‐expressing cells were identified using immunostaining. Myofibroblasts, activated fibroblasts, endothelial cells, and myeloid cells were quantified with specific markers.Results: After transplantation, 89 ± 8.9% of mononuclear cells in the blood expressed the GFP and about 50% of adherent cells in the bone marrow. Tissue obtained during initial wounding contained only minor numbers of GFP‐positive cells, like adjacent control tissue. Following wound healing, 8.1 ± 5.1% of all cells in the wound area were positive, and 5.0 ± 4.0% of the myofibroblasts, which was significantly higher than in adjacent tissue. Similar percentages were found for activated fibroblasts and endothelial cells, but for myeloid cells it was considerably higher (22 ± 9%).Conclusions: Bone marrow‐derived cells contribute to palatal wound healing, but are not the main source of myofibroblasts. In small wounds, the local precursor cells are probably sufficient to replenish the defect.
Title: Bone marrow‐derived cells in palatal wound healing
Description:
Oral Diseases (2010) 16, 788–794Objective: Myofibroblasts are responsible for contraction and scarring after cleft palate repair.
This leads to growth disturbances in the upper jaw.
We hypothesized that cells from the bone marrow are recruited to palatal wounds and differentiate into myofibroblasts.
Methods: We transplanted bone marrow from green fluorescent protein (GFP)‐transgenic rats into lethally irradiated wild‐type rats.
After recovery, experimental wounds were made in the palatal mucoperiosteum, and harvested 2 weeks later.
GFP‐expressing cells were identified using immunostaining.
Myofibroblasts, activated fibroblasts, endothelial cells, and myeloid cells were quantified with specific markers.
Results: After transplantation, 89 ± 8.
9% of mononuclear cells in the blood expressed the GFP and about 50% of adherent cells in the bone marrow.
Tissue obtained during initial wounding contained only minor numbers of GFP‐positive cells, like adjacent control tissue.
Following wound healing, 8.
1 ± 5.
1% of all cells in the wound area were positive, and 5.
0 ± 4.
0% of the myofibroblasts, which was significantly higher than in adjacent tissue.
Similar percentages were found for activated fibroblasts and endothelial cells, but for myeloid cells it was considerably higher (22 ± 9%).
Conclusions: Bone marrow‐derived cells contribute to palatal wound healing, but are not the main source of myofibroblasts.
In small wounds, the local precursor cells are probably sufficient to replenish the defect.
Related Results
Arhgap21 Expression in Bone Marrow Niche Is Crucial for Hematopoietic Progenitor Homing and Short Term Reconstitution after Transplantation
Arhgap21 Expression in Bone Marrow Niche Is Crucial for Hematopoietic Progenitor Homing and Short Term Reconstitution after Transplantation
Abstract
The microenvironment of the bone marrow (BM) is essential for retention and migration of hematopoietic progenitor cells. ARHGAP21 is a negative regulator of...
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives: Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 BMPs identified to da...
Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing
Myeloma Cell-Derived Runx2 Promotes Myeloma Progression and Bone-Homing
Abstract
Background. Multiple myeloma (MM), an incurable plasma-cell malignancy, preferentially grows in bone marrow and frequently metastasizes to new bone sites. T...
Bone Marrow
Bone Marrow
AbstractThe bone marrow is a highly dynamic organ located within the cavities of bones. The main role of the bone marrow is to facilitate the production of all the blood cells requ...
p62 Signaling Is Increased in Multiple Myeloma Microenvironment.
p62 Signaling Is Increased in Multiple Myeloma Microenvironment.
Abstract
The bone microenvironment plays a critical role in promoting both tumor growth and bone destruction in myeloma (MM). Marrow stromal cells produce factors, w...
The irradiated human mandible
The irradiated human mandible
Mandibular bone is known to be susceptible to irradiation damage, especially when radiation dose exceeds 50 Gy. This can result in compromised wound healing and ultimately osteorad...
Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?
Could rituximab be a silver lining in refractory bone marrow fibrosis caused by lupus?
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that can present with a variety of clinical manifestations, ranging from mild skin involvement to multisystemic ...
Automatic Bone Marrow Cell Identification and Classification By Deep Neural Network
Automatic Bone Marrow Cell Identification and Classification By Deep Neural Network
Purpose
Differential counting of blood cells is the basis of diagnostic hematology. In many circumstances, identification of cells in bone marrow smears is the golde...

